The Potential Role of Apigenin in Cancer Prevention and Treatment.
Arshad Husain RahmaniMohammed A AlsahliAhmad Abdulaziz A AlmatroudiMashael Abdullah AlmogbelAmjad Ali KhanShehwaz AnwarSaleh A AlmatroodiPublished in: Molecules (Basel, Switzerland) (2022)
Cancer is the leading cause of death worldwide. In spite of advances in the treatment of cancer, currently used treatment modules including chemotherapy, hormone therapy, radiation therapy and targeted therapy causes adverse effects and kills the normal cells. Therefore, the goal of more effective and less side effects-based cancer treatment approaches is still at the primary position of present research. Medicinal plants or their bioactive ingredients act as dynamic sources of drugs due to their having less side effects and also shows the role in reduction of resistance against cancer therapy. Apigenin is an edible plant-derived flavonoid that has received significant scientific consideration for its health-promoting potential through modulation of inflammation, oxidative stress and various other biological activities. Moreover, the anti-cancer potential of apigenin is confirmed through its ability to modulate various cell signalling pathways, including tumor suppressor genes, angiogenesis, apoptosis, cell cycle, inflammation, apoptosis, PI3K/AKT, NF-κB, MAPK/ERK and STAT3 pathways. The current review mainly emphases the potential role of apigenin in different types of cancer through the modulation of various cell signaling pathways. Further studies based on clinical trials are needed to explore the role of apigenin in cancer management and explain the possible potential mechanisms of action in this vista.
Keyphrases
- oxidative stress
- pi k akt
- signaling pathway
- cell cycle arrest
- papillary thyroid
- cell cycle
- cell proliferation
- squamous cell
- radiation therapy
- clinical trial
- induced apoptosis
- cancer therapy
- squamous cell carcinoma
- healthcare
- cell death
- stem cells
- drug delivery
- lymph node metastasis
- immune response
- genome wide
- randomized controlled trial
- young adults
- childhood cancer
- mental health
- dna methylation
- ischemia reperfusion injury
- health information
- study protocol
- vascular endothelial growth factor
- toll like receptor
- smoking cessation